University of Ioannina
Isolation and characterization of breast cancer stem cells: the role of histone demethylase LSD1 in the biology of breast cancer stem cells
Abstract
dc:descriptionCancer stem cells (CSCs) constitute a cancer cell subpopulation with self-renewal and differentiation properties that are thought to sustain tumor growth and relapse after therapy. The ability of CSCs to survive after conventional anticancer treatment has spurred a major effort for the development of new therapeutic strategies that target these cells. Recent studies, suggest that, the unique properties of CSCs appear to be under epigenetic regulation. LSD1/KDM1A, a histone demethylase, is a stemness regulator while is also overexpressed in different human cancer types including breast cancer. In the present work, our aim was to investigate LSD1’s role in the chemoresistance of breast CSCs (bCSCs). Immunohistochemistry experiments in breast cancer tumor samples confirmed the association of LSD1 expression with less differentiated breast tumors. Moreover, manipulation of LSD1 expression with different experimental approaches associated the demethylase with the chemoresistance of breast cancer cells. In addition, we have established and characterize an in vitro mammosphere culture system enriched in bCSCs, knock-down and overexpression experiments showed that the enzyme could regulate the stemness properties of the CD44+/CD24-/low bCSC sub-population. Moreover, pharmacological inhibition of LSD1 led to a reduction of the bCSCs and impairment of its stemness potential in vitro, while it was able to restrain tumor growth, as well as, to decrease the bCSCs sub-population in vivo. Finally, chemotherapy resistance of bCSCs was confirmed in our system; however, pretreatment with an LSD1 inhibitor rendered the bCSCs more sensitive to these commonly used therapeutic modalities as shown by cell proliferation and mammosphere formation assays. Experiments with xenografts in mice are underway to confirm that LSD1 targeting in combination with chemotherapeutic agents is more efficient in inhibiting tumor growth. The above data strongly suggest that LSD1 is a druggable target in bCSCs as it was found to regulate their stemness properties and thus conferring to them chemoresistance abilities.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Verigos, Ioannis
- Βερίγος, Ιωάννης
Subjects
dc:subject × 21- Καρκινικά βλαστικά κύτταρα
- Επιγενετική
- Καρκίνος μαστού
- Απομεθυλάση ιστονών
- Χημειοανθεκτικότητα
- Συνδυαστική θεραπεία
- Cancer stem cells
- Epigenetics
- LSD1
- KDM1A
- Breast cancer
- Chemoresistance
- Combination therapy
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46994